Wildcat Capital Management’s MiMedx Group MDXG Stock Holding History

Wildcat Capital Management’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-500,000	Closed	-$5.94M	–	16
2017 Q3	$5.94M	Buy	+500,000	New	+$7.42M	1.07%	8
2017 Q2	–	Sell	-1,080,365	Closed	-$14.4M	–	19
2017 Q1	$10.3M	Hold	1,080,365	–	–	3.26%	6
2016 Q4	$9.57M	Hold	1,080,365	–	–	4.4%	5
2016 Q3	$9.27M	Hold	1,080,365	–	–	2.79%	7
2016 Q2	$8.62M	Buy	1,080,365 +125,000	+13%	+$973K	3.25%	6
2016 Q1	$8.35M	Hold	955,365	–	–	2.9%	8
2015 Q4	$8.95M	Buy	955,365 +690,842	+261%	+$5.99M	2.53%	6
2015 Q3	$2.55M	Hold	264,523	–	–	0.95%	8
2015 Q2	$3.07M	Sell	264,523 -766,902	-74%	-$7.89M	1.05%	11
2015 Q1	$10.7M	Buy	1,031,425 +483,525	+88%	+$4.53M	4.16%	4
2014 Q4	$6.32M	Buy	+547,900	New	+$5.41M	2.6%	6

Other funds holding MDXG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Wildcat Capital Management's MDXG Position: Q4 2017 in Review

Wildcat Capital Management sold out of MiMedx Group (MDXG) in Q4 2017, closing a stake of 500,000 shares — an estimated $5.94M sold.

Wildcat Capital Management first reported a position in MDXG in Q4 2014 and held it in 11 quarters. The position peaked at $10.7M in Q1 2015. 236 funds tracked by Wall St. Rank hold MDXG as of Q4 2017.

Wildcat Capital Management reported no remaining MiMedx Group position as of Q4 2017 after selling out during the quarter.
Wildcat Capital Management sold 500,000 MiMedx Group shares in Q4 2017, an estimated $5.94M.
Wildcat Capital Management first reported a position in MiMedx Group in Q4 2014 and held it in 11 quarters.
Wildcat Capital Management's MiMedx Group position peaked at $10.7M in Q1 2015.
236 funds tracked by Wall St. Rank held MiMedx Group as of Q4 2017.

Based on Wildcat Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.